Yayın:
Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study

dc.contributor.buuauthorSınırtaş, Melda
dc.contributor.buuauthorAkalın, Halis
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıbbi Mikrobiyoloji Ana Bilim Dalı
dc.contributor.departmentEnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.contributor.researcheridAAU-8952-2020
dc.contributor.scopusid57112463700
dc.contributor.scopusid57207553671
dc.date.accessioned2022-10-12T08:45:45Z
dc.date.available2022-10-12T08:45:45Z
dc.date.issued2016-02-09
dc.descriptionÇalışmada 22 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.
dc.description.abstractBackground: Staphylococcus aureus is one of the causes of both community and healthcare-associated bacteremia. The attributable mortality of S. aureus bacteremia (SAB) is still higher and predictors for mortality and clinical outcomes of this condition are need to be clarified. In this prospective observational study, we aimed to examine the predictive factors for mortality in patients with SAB in eight Turkish tertiary care hospitals. Methods: Adult patients with signs and symptoms of bacteremia with positive blood cultures for S. aureus were included. All data for episodes of SAB including demographics, clinical and laboratory findings, antibiotics, and outcome were recorded for a 3-year (2010-2012) period. Cox proportional hazard model with forward selection was used to assess the independent effect of risk factors on mortality. A 28-day mortality was the dependent variable in the Cox regression analysis. Results: A total of 255 episodes of SAB were enrolled. The median age of the patients was 59 years. Fifty-five percent of the episodes were considered as primary SAB and vascular catheter was the source of 42.1 %. Healthcare associated SAB was defined in 55.7 %. Blood cultures yielded methicillin-resistant S. aureus (MRSA) as a cause of SAB in 39.2 %. Initial empirical therapy was inappropriate in 28.2 %. Although overall mortality was observed in 52 (20.4 %), 28-day mortality rate was 15.3 %. Both the numbers of initial inappropriate empirical antibiotic treatment and the median hours to start an appropriate antibiotic between the cases of fatal outcome and survivors after fever onset were found to be similar (12/39 vs 60/216 and 6 vs 12 h, respectively; p > 0.05). High Charlson comorbidity index (CCI) score (p = 0.002), MRSA (p = 0.017), intensive care unit (ICU) admission (p < 0.001) and prior exposure to antibiotics (p = 0.002) all were significantly associated with mortality. The Cox analysis defined age [Hazard Ratio (HR) 1.03; p = 0.023], ICU admission (HR 6.9; p = 0.002), and high CCI score (HR 1.32; p = 0.002) as the independent predictive factors mortality. Conclusions: The results of this prospective study showed that age, ICU stay and high CCI score of a patient were the independent predictors of mortality and MRSA was also significantly associated with mortality in SAB.
dc.identifier.citationYılmaz, M. vd. (2016). "Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study". Annals of Clinical Microbiology and Antimicrobials, 15(1).
dc.identifier.doi10.1186/s12941-016-0122-8
dc.identifier.issn1476-0711
dc.identifier.issue1
dc.identifier.pubmed26860463
dc.identifier.scopus2-s2.0-84957870054
dc.identifier.urihttps://doi.org/10.1186/s12941-016-0122-8
dc.identifier.urihttps://ann-clinmicrob.biomedcentral.com/articles/10.1186/s12941-016-0122-8
dc.identifier.urihttp://hdl.handle.net/11452/29062
dc.identifier.volume15
dc.identifier.wos000369571000002
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherBMC
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalAnnals of Clinical Microbiology and Antimicrobials
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMicrobiology
dc.subjectStaphylococcus aureus
dc.subjectBacteremia
dc.subjectRisk factors
dc.subjectMortality
dc.subjectSepsis
dc.subjectBlood-stream infection
dc.subjectHacettepe university adult
dc.subjectMethicillin-resistant
dc.subjectRisk-factors
dc.subjectClinical impact
dc.subjectAntimicrobial therapy
dc.subjectAntibiotic-treatment
dc.subject30-day mortality
dc.subjectEndocarditis
dc.subjectEpidemiology
dc.subject.emtreeAmoxicillin
dc.subject.emtreeCefazolin
dc.subject.emtreeCefepime
dc.subject.emtreeCefoperazone plus sulbactam
dc.subject.emtreeCeftazidime
dc.subject.emtreeCeftriaxone
dc.subject.emtreeCefuroxime
dc.subject.emtreeDaptomycin
dc.subject.emtreeImipenem
dc.subject.emtreeLinezolid
dc.subject.emtreeMeropenem
dc.subject.emtreePiperacillin plus tazobactam
dc.subject.emtreeSultamicillin
dc.subject.emtreeTeicoplanin
dc.subject.emtreeTimentin
dc.subject.emtreeVancomycin
dc.subject.emtreeAntiinfective agent
dc.subject.emtreeAdolescent
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeBlood culture
dc.subject.emtreeCharlson comorbidity index
dc.subject.emtreeControlled study
dc.subject.emtreeDemography
dc.subject.emtreeDependent variable
dc.subject.emtreeDrug exposure
dc.subject.emtreeFatality
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeIntensive care unit
dc.subject.emtreeIntravascular catheter
dc.subject.emtreeLaboratory test
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMethicillin resistant staphylococcus aureus
dc.subject.emtreeMortality
dc.subject.emtreeMulticenter study
dc.subject.emtreeObservational study
dc.subject.emtreeProspective study
dc.subject.emtreeRisk factor
dc.subject.emtreeScoring system
dc.subject.emtreeStaphylococcal bacteremia
dc.subject.emtreeStaphylococcus aureus
dc.subject.emtreeSymptomatology
dc.subject.emtreeTertiary health care
dc.subject.emtreeAged
dc.subject.emtreeBacteremia
dc.subject.emtreeClassification
dc.subject.emtreeClinical trial
dc.subject.emtreeGenetics
dc.subject.emtreeIsolation and purification
dc.subject.emtreeMicrobiology
dc.subject.emtreeMiddle aged
dc.subject.emtreeMortality
dc.subject.emtreeStaphylococcus infection
dc.subject.emtreeStatistics and numerical data
dc.subject.emtreeTurkey
dc.subject.emtreeVery elderly
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAnti-bacterial agents
dc.subject.meshBacteremia
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIntensive care units
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshProspective studies
dc.subject.meshStaphylococcal infections
dc.subject.meshStaphylococcus aureus
dc.subject.meshTurkey
dc.subject.scopusBacteremia; Staphylococcal Infections; Staphylococcus Aureus
dc.subject.wosMicrobiology
dc.titleMortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Tıbbi Mikrobiyoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Sınırtaş_vd_2016.pdf
Boyut:
1.1 MB
Format:
Adobe Portable Document Format
Açıklama

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama